Steven Favaloro, incoming Genezen CEO (L) and Mark Womack, incoming BioCina CEO
March 16, 2023 11:33 AM EDT
People
Manufacturing

Con­tract man­u­fac­tur­ers BioCi­na and Genezen name new CEOs

Tyler Patchen

News Reporter

A pair of CD­MOs are bring­ing in new CEOs.

Tak­ing the helm at BioCi­na is Mark Wom­ack. Ac­cord­ing to his LinkedIn

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pa­tient dies in Neu­ro­gene's Rett syn­drome study

Lil­ly's board un­der­goes more changes; Mer­ck strat­e­gy chief joins Roger Perl­mut­ter at Eikon

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Mi­crosoft-backed Enve­da rais­es $130M for drugs in I&I, obe­si­ty and oth­er ar­eas

As­traZeneca culls Phase 2 opi­oid use dis­or­der drug

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times